Clinical Trial Detail

NCT ID NCT01961843
Title Abiraterone Acetate for Castrate Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

prostate adenocarcinoma

Therapies

Prednisone

Abiraterone

Age Groups: adult

No variant requirements are available.